FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2013786644> ?p ?o ?g. }

• W2013786644 endingPage "919" @default.
• W2013786644 startingPage "917" @default.
• W2013786644 abstract "Pediatric Blood & CancerVolume 53, Issue 6 p. 917-919 Highlight Childhood and adolescent lymphoblastic lymphoma: End of the beginning and future directions Jessica Hochberg MD, Jessica Hochberg MD Pediatrics, Morgan Stanley Children's Hospital of New York Presbyterian, Columbia University, New York, New YorkSearch for more papers by this authorMitchell S. Cairo MD, Corresponding Author Mitchell S. Cairo MD [email protected] Pediatrics, Morgan Stanley Children's Hospital of New York Presbyterian, Columbia University, New York, New York Medicine, Morgan Stanley Children's Hospital of New York Presbyterian, Columbia University, New York, New York Pathology, Morgan Stanley Children's Hospital of New York Presbyterian, Columbia University, New York, New YorkChief, Division of Pediatric Blood and Marrow Transplantation, Professor of Pediatrics, Medicine, Pathology, Columbia University, 3959 Broadway, CHN 10-03, New York, NY 10032.===Search for more papers by this author Jessica Hochberg MD, Jessica Hochberg MD Pediatrics, Morgan Stanley Children's Hospital of New York Presbyterian, Columbia University, New York, New YorkSearch for more papers by this authorMitchell S. Cairo MD, Corresponding Author Mitchell S. Cairo MD [email protected] Pediatrics, Morgan Stanley Children's Hospital of New York Presbyterian, Columbia University, New York, New York Medicine, Morgan Stanley Children's Hospital of New York Presbyterian, Columbia University, New York, New York Pathology, Morgan Stanley Children's Hospital of New York Presbyterian, Columbia University, New York, New YorkChief, Division of Pediatric Blood and Marrow Transplantation, Professor of Pediatrics, Medicine, Pathology, Columbia University, 3959 Broadway, CHN 10-03, New York, NY 10032.===Search for more papers by this author First published: 11 August 2009 https://doi.org/10.1002/pbc.22216Citations: 4Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat REFERENCES 1 Wollner N, Burchenal JH, Lieberman PH, et al. Non-Hodgkin's lymphoma in children. A comparative study of two modalities of therapy. Cancer 1976; 37: 123–134. 2 Pillon M, Piglione M, Garaventa A, et al. Long-term results of AIEOP LNH-92 protocol for the treatment of pediatric lymphoblastic lymphoma: A report of the Italian Association of pediatric hematology and oncology. Pediatr Blood Cancer 2009; DOI: 10.1002/pbc.22162. 3 Patte C, Kalifa C, Flamant F, et al. Results of the LMT81 protocol, a modified LSA2L2 protocol with high dose methotrexate, on 84 children with non-B-cell (lymphoblastic) lymphoma. Med Pediatr Oncol 1992; 20: 105–113. 4 Link MP, Donaldson SS, Berard CW, et al. Results of treatment of childhood localized non-Hodgkin's lymphoma with combination chemotherapy with or without radiotherapy. N Engl J Med 1990; 322: 1169–1174. 5 Link MP, Shuster JJ, Donaldson SS, et al. Treatment of children and young adults with early-stage non-Hodgkin's lymphoma. N Engl J Med 1997; 337: 1259–1266. 6 Meadows AT, Sposto R, Jenkin RD, et al. Similar efficacy of 6 and 18 months of therapy with four drugs (COMP) for localized non-Hodgkin's lymphoma of children: A report from the Childrens Cancer Study Group. J Clin Oncol 1989; 7: 92–99. 7 Termuhlen A, Lynch J, Perkins SL, et al. Outcome of newly diagnosed children and adolescents with localized lymphoblastic lymphoma treated on COG A5971: A Report from the Children's Oncology Group. Hematol Meet Rep 2009; 3: 35, #59. 8 Mora J, Filippa DA, Qin J, Wollner N. Lymphoblastic lymphoma of childhood and the LSA2-L2 protocol: The 30-year experience at Memorial-Sloan-Kettering Cancer Center. Cancer 2003; 98: 1283–1291. 9 Burkhardt B, Woessmann W, Zimmermann M, et al. Impact of cranial radiotherapy on central nervous system prophylaxis in children and adolescents with central nervous system-negative stage III or IV lymphoblastic lymphoma. J Clin Oncol 2006; 24: 491–499. 10 Reiter A, Schrappe M, Ludwig WD, et al. Intensive ALL-type therapy without local radiotherapy provides a 90% event-free survival for children with T-cell lymphoblastic lymphoma: A BFM group report. Blood 2000; 95: 416–421. 11 Woessmann W, Seidemann K, Mann G, et al. The impact of the methotrexate administration schedule and dose in the treatment of children and adolescents with B-cell neoplasms: A report of the BFM Group Study NHL-BFM95. Blood 2005; 105: 948–958. 12 Abromowitch M, Sposto R, Perkins S, et al. Shortened intensified multi-agent chemotherapy and non-cross resistant maintenance therapy for advanced lymphoblastic lymphoma in children and adolescents: Report from the Children's Oncology Group. Br J Haematol 2008; 143: 261–267. 13 Abromowitch M, Termuhlen A, Lynch J, et al. High dose methotrexate and early intensification of therapy do not improve 3 year EFS in children and adolescents with disseminated lymphoblastic lymphoma. Results of the randomized arms of COG A5971. Hematol Meet Rep 2009; 3: 33, #56. 14 Anderson JR, Jenkin RD, Wilson JF, et al. Long-term follow-up of patients treated with COMP or LSA2L2 therapy for childhood non-Hodgkin's lymphoma: A report of CCG-551 from the Childrens Cancer Group. J Clin Oncol 1993; 11: 1024–1032. 15 Tubergen DG, Krailo MD, Meadows AT, et al. Comparison of treatment regimens for pediatric lymphoblastic non-Hodgkin's lymphoma: A Childrens Cancer Group study. J Clin Oncol 1995; 13: 1368–1376. 16 Eden OB, Hann I, Imeson J, et al. Treatment of advanced stage T cell lymphoblastic lymphoma: Results of the United Kingdom Children's Cancer Study Group (UKCCSG) protocol 8503. Br J Haematol 1992; 82: 310–316. 17 Uyttebroeck A, Suciu S, Laureys G, et al. Treatment of childhood T-cell lymphoblastic lymphoma according to the strategy for acute lymphoblastic leukaemia, without radiotherapy: Long term results of the EORTC CLG 58881 trial. Eur J Cancer 2008; 44: 840–846. 18 Burkhardt B, Bruch J, Zimmermann M, et al. Loss of heterozygosity on chromosome 6q14-q24 is associated with poor outcome in children and adolescents with T-cell lymphoblastic lymphoma. Leukemia 2006; 20: 1422–1429. 19 Berg SL, Blaney SM, Devidas M, et al. Phase II study of nelarabine (compound 506U78) in children and young adults with refractory T-cell malignancies: A report from the Children's Oncology Group. J Clin Oncol 2005; 23: 3376–3382. 20 Chan SM, Weng AP, Tibshirani R, et al. Notch signals positively regulate activity of the mTOR pathway in T-cell acute lymphoblastic leukemia. Blood 2007; 110: 278–286. 21 Baleydier F, Asnafi V, Lengline E, et al. NOTCH1/FBXW7 mutational status differs qualitatively and quantitatively in T-lineage lymphoblastic lymphoma (T-LL) and leukemia (T-ALL). Hematol Meet Rep 2009; 3: 34, #58. 22 Raetz EA, Perkins SL, Bhojwani D, et al. Gene expression profiling reveals intrinsic differences between T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma. Pediatr Blood Cancer 2006; 47: 130–140. 23 Basso K, Mussolin L. Lettieri A, et al. T-LBL and T-ALL: Differences and similarities detected by genomic and transcriptomic analyses. Hematol Meet Rep 2009; 3: 35, #60. 24 Frazer JK, Meeker ND, Rudner L, et al. Heritable T-cell malignancy models established in a zebrafish phenotypic screen. Leukemia 2009; DOI: 10.1038/leu.2009.116. Citing Literature Volume53, Issue61 December 2009Pages 917-919 ReferencesRelatedInformation" @default.
• W2013786644 created "2016-06-24" @default.
• W2013786644 creator A5001697191 @default.
• W2013786644 creator A5005741602 @default.
• W2013786644 date "2009-08-11" @default.
• W2013786644 modified "2023-09-27" @default.
• W2013786644 title "Childhood and adolescent lymphoblastic lymphoma: End of the beginning and future directions" @default.
• W2013786644 cites W1900138902 @default.
• W2013786644 cites W1950142574 @default.
• W2013786644 cites W1963656087 @default.
• W2013786644 cites W1984001033 @default.
• W2013786644 cites W1990575337 @default.
• W2013786644 cites W1999967194 @default.
• W2013786644 cites W2005108658 @default.
• W2013786644 cites W2019314170 @default.
• W2013786644 cites W2054507081 @default.
• W2013786644 cites W2056949729 @default.
• W2013786644 cites W2061016502 @default.
• W2013786644 cites W2093958150 @default.
• W2013786644 cites W2106933841 @default.
• W2013786644 cites W2109279403 @default.
• W2013786644 cites W2115482777 @default.
• W2013786644 cites W2124303054 @default.
• W2013786644 cites W2159263318 @default.
• W2013786644 cites W2310146029 @default.
• W2013786644 cites W2336895600 @default.
• W2013786644 doi "https://doi.org/10.1002/pbc.22216" @default.
• W2013786644 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19672977" @default.
• W2013786644 hasPublicationYear "2009" @default.
• W2013786644 type Work @default.
• W2013786644 sameAs 2013786644 @default.
• W2013786644 citedByCount "4" @default.
• W2013786644 countsByYear W20137866442012 @default.
• W2013786644 countsByYear W20137866442017 @default.
• W2013786644 countsByYear W20137866442023 @default.
• W2013786644 crossrefType "journal-article" @default.
• W2013786644 hasAuthorship W2013786644A5001697191 @default.
• W2013786644 hasAuthorship W2013786644A5005741602 @default.
• W2013786644 hasConcept C187212893 @default.
• W2013786644 hasConcept C203014093 @default.
• W2013786644 hasConcept C2776090121 @default.
• W2013786644 hasConcept C2777478502 @default.
• W2013786644 hasConcept C2778461978 @default.
• W2013786644 hasConcept C2779338263 @default.
• W2013786644 hasConcept C2909962599 @default.
• W2013786644 hasConcept C71924100 @default.
• W2013786644 hasConcept C8891405 @default.
• W2013786644 hasConceptScore W2013786644C187212893 @default.
• W2013786644 hasConceptScore W2013786644C203014093 @default.
• W2013786644 hasConceptScore W2013786644C2776090121 @default.
• W2013786644 hasConceptScore W2013786644C2777478502 @default.
• W2013786644 hasConceptScore W2013786644C2778461978 @default.
• W2013786644 hasConceptScore W2013786644C2779338263 @default.
• W2013786644 hasConceptScore W2013786644C2909962599 @default.
• W2013786644 hasConceptScore W2013786644C71924100 @default.
• W2013786644 hasConceptScore W2013786644C8891405 @default.
• W2013786644 hasIssue "6" @default.
• W2013786644 hasLocation W20137866441 @default.
• W2013786644 hasLocation W20137866442 @default.
• W2013786644 hasOpenAccess W2013786644 @default.
• W2013786644 hasPrimaryLocation W20137866441 @default.
• W2013786644 hasRelatedWork W1583076840 @default.
• W2013786644 hasRelatedWork W2017272663 @default.
• W2013786644 hasRelatedWork W2024019248 @default.
• W2013786644 hasRelatedWork W2100358456 @default.
• W2013786644 hasRelatedWork W2270423248 @default.
• W2013786644 hasRelatedWork W2407161884 @default.
• W2013786644 hasRelatedWork W2410889947 @default.
• W2013786644 hasRelatedWork W2805650661 @default.
• W2013786644 hasRelatedWork W2905352035 @default.
• W2013786644 hasRelatedWork W2979048692 @default.
• W2013786644 hasVolume "53" @default.
• W2013786644 isParatext "false" @default.
• W2013786644 isRetracted "false" @default.
• W2013786644 magId "2013786644" @default.
• W2013786644 workType "article" @default.